These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33327542)

  • 21. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Breast Cancer Stem Cells.
    Zhang L; Chen W; Liu S; Chen C
    Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
    Li L; Xiong Y; Wang N; Zhu M; Gu Y
    Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
    Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
    Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
    FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
    Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.
    He L; Wick N; Germans SK; Peng Y
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells.
    He L; Gu J; Lim LY; Yuan ZX; Mo J
    Front Pharmacol; 2016; 7():313. PubMed ID: 27679576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy as a Therapeutic Target in Breast Tumors: The Cancer stem cell perspective.
    Raza S; Siddiqui JA; Srivastava A; Chattopadhyay N; Sinha RA; Chakravarti B
    Autophagy Rep; 2024 Dec; 3(1):. PubMed ID: 39006309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer stem cells: are we ready to go from bench to bedside?
    Lin CY; Barry-Holson KQ; Allison KH
    Histopathology; 2016 Jan; 68(1):119-37. PubMed ID: 26768034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to trastuzumab and investigation of expression profiles of matrix metalloproteinase-related proteins in primary breast cancer stem cells.
    Koygun GK; Kars MD; Emsen A; Artac H; Aksoy F; Cakir M; Tavli L; Artac M
    Clin Exp Med; 2021 Aug; 21(3):447-456. PubMed ID: 33471244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs in breast cancer stem cells.
    Huang Y; Mo W; Ding X; Ding Y
    Med Oncol; 2023 May; 40(6):177. PubMed ID: 37178429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.
    Sridharan S; Howard CM; Tilley AMC; Subramaniyan B; Tiwari AK; Ruch RJ; Raman D
    Front Oncol; 2019; 9():1003. PubMed ID: 31681564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results.
    Pham PV; Le HT; Vu BT; Pham VQ; Le PM; Phan NL; Trinh NV; Nguyen HT; Nguyen ST; Nguyen TL; Phan NK
    Onco Targets Ther; 2016; 9():4441-51. PubMed ID: 27499638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
    Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
    Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1.
    Das JK; Deoraj A; Roy D; Felty Q
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2881-2891. PubMed ID: 35678885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications.
    Conde I; Ribeiro AS; Paredes J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.